SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001607062-17-000118
Filing Date
2017-03-30
Accepted
2017-03-30 17:00:16
Documents
56
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A rgbp033115form10qa.htm 10-Q/A 609116
2 EXHIBIT 31_1 ex31_1.htm EX-31.1 10003
3 EXHIBIT 31_2 ex31_2.htm EX-31.2 9951
4 EXHIBIT 32_1 ex32_1.htm EX-32.1 5482
5 EXHIBIT 32_2 ex32_2.htm EX-32.2 5487
  Complete submission text file 0001607062-17-000118.txt   2922392

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rgbp-20150331.xml EX-101.INS 509998
7 XBRL SCHEMA FILE rgbp-20150331.xsd EX-101.SCH 32900
8 XBRL CALCULATION FILE rgbp-20150331_cal.xml EX-101.CAL 29279
9 XBRL DEFINITION FILE rgbp-20150331_def.xml EX-101.DEF 112111
10 XBRL LABEL FILE rgbp-20150331_lab.xml EX-101.LAB 151456
11 XBRL PRESENTATION FILE rgbp-20150331_pre.xml EX-101.PRE 167201
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q/A | Act: 34 | File No.: 333-191725 | Film No.: 17726564
SIC: 2834 Pharmaceutical Preparations